PharmAthene, Inc. (PIP)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
2.560.00 (0.00%)
At close: 4:02 PM EDT
People also watch:
SIGAPLXRNNOPXASNSS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.54
Prev Close2.56
Bid2.55 x 5900
Ask2.56 x 2400
Day's Range2.53 - 2.57
52wk Range1.20 - 2.60
1y Target EstN/A
Market Cap167.92M
P/E Ratio (ttm)41.29
Beta1.80
Volume85,076
Avg Vol (3m)270,812
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process

    ANNAPOLIS, Md., Aug. 25, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that after discussions with the ...

  • PR Newswire20 days ago

    PharmAthene Files Protest Against HHS Over Anthrax Vaccine Bidding Process

    ANNAPOLIS, Md., Aug. 5, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today filed a formal protest against the Department of Health and Human Services, challenging its solicitation for a next-generation Anthrax vaccine provider. According to the protest, filed with the U.S. Government Accountability Office, the government's "Request for Proposals" was written in a way that eliminates competition and assures a sole source award to Emergent BioSolutions Inc., the company that has long been the sole-source provider of the vaccine. The protest requests the GAO suspend the award under the solicitation while it reviews PharmAthene's complaint.

  • PR Newswire21 days ago

    PharmAthene Reports Second Quarter 2016 Financial and Operational Results

    ANNAPOLIS, Md., Aug. 4, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results ...